These are peer-reviewed papers I have published on dementia and other neurodegenerative diseases, which I hope you find helpful.
Rahman S, Sahakian BJ, Hodges JR, Rogers RD, Robbins TW. Specific cognitive deficits in mild frontal variant frontotemporal dementia. Brain. 1999 Aug;122 ( Pt 8):1469-93.
Rahman S, Robbins TW, Sahakian BJ.Comparative cognitive neuropsychological studies of frontal lobe function: implications for therapeutic strategies in frontal variant frontotemporal dementia. Dement Geriatr Cogn Disord. 1999;10 Suppl 1:15-28.
cited in the current Oxford Textbook of medicine chapter on dementia
Rahman S, Sahakian BJ, Cardinal RN, Rogers RD, Robbins T. Decision making and neuropsychiatry. Trends Cogn Sci. 2001 Jun 1;5(6):271-277.
Lee AC, Rahman S, Hodges JR, Sahakian BJ, Graham KS. Associative and recognition memory for novel objects in dementia: implications for diagnosis. Eur J Neurosci. 2003 Sep;18(6):1660-70.
Deakin JB, Rahman S, Nestor PJ, Hodges JR, Sahakian BJ. Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial. Psychopharmacology (Berl). 2004 Apr;172(4):400-8. Epub 2003 Dec 10.
Rahman S, Robbins TW, Hodges JR, Mehta MA, Nestor PJ, Clark L, Sahakian BJ. Methylphenidate (‘Ritalin’) can ameliorate abnormal risk-taking behavior in the frontal variant of frontotemporal dementia. Neuropsychopharmacology. 2006 Mar;31(3):651-8.
Rahman S, Griffin HJ, Quinn NP, Jahanshahi M. Quality of life in Parkinson’s disease: the relative importance of the symptoms. Mov Disord. 2008 Jul 30;23(10):1428-34. doi: 10.1002/mds.21667.
Rahman S, Griffin HJ, Quinn NP, Jahanshahi M. The factors that induce or overcome freezing of gait in Parkinson’s disease. Behav Neurol. 2008;19(3):127-36.
Also the paper I did with Karen Dening, head of research and evaluation, earlier this year for Nursing Times on the critical importance of clinical nursing specialists in provision of high quality dementia care.